Business
Platinum leads immuno-oncology company HaemaLogiX’s $10m round – The Australian Financial Review
Blood cancer immuno-oncology comapny HaemaLogiX is the latest to raise capital, bringing on Platinum Asset Management as its…
KappaMab is designed to enable the immune system to recognise the abnormal cancer cells and kill them.
Platinum Asset Management fund manager Bianca Ogden said the fund had been following the progress of HaemaLogiX and believed now was the right time to…
Continue Reading
-
General17 hours agoAustralia Kangaroos lose Xavier Coates and Zac Lomax ahead of rugby league Ashes in England
-
Noosa News23 hours agoSuncorp Stadium upgrades to rival Sydney as seat capacity and infrastructure prioritised
-
Noosa News21 hours agoThree steps Queensland SES want you to know to Get Ready for severe weather
-
Noosa News23 hours agoIn Trent Dalton’s new book Gravity Let Me Go, the bestselling author interrogates himself